Yin-Hang Yu

790 total citations
17 papers, 651 citations indexed

About

Yin-Hang Yu is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Yin-Hang Yu has authored 17 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in Yin-Hang Yu's work include Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (5 papers) and Virus-based gene therapy research (4 papers). Yin-Hang Yu is often cited by papers focused on Fibroblast Growth Factor Research (8 papers), Kruppel-like factors research (5 papers) and Virus-based gene therapy research (4 papers). Yin-Hang Yu collaborates with scholars based in China and United States. Yin-Hang Yu's co-authors include Guiping Ren, Siming Li, Deshan Li, Fuliang Bai, Wenfei Wang, Guiyou Tian, Yaonan Liu, Qingyan Yuan, Yunye Liu and Liying Song and has published in prestigious journals such as Pharmacology Biochemistry and Behavior, Molecular and Cellular Biochemistry and International Immunopharmacology.

In The Last Decade

Yin-Hang Yu

17 papers receiving 635 citations

Peers

Yin-Hang Yu

GENET

EPIDE

IMMUN

PHYSI

Bassam Abu‐Libdeh Israel

Kun Dong China

Winston Thomas United States

Zhen Miao United States

Teng Lü China

Ying Yan China

Cheryl de Vallière Switzerland

Fuu‐Jen Tsai Taiwan

Tomoyasu Hattori Japan

Bassam Abu‐Libdeh Israel

Yin-Hang Yu

403 ×1.0

91 ×0.9

GENET

69 ×0.7

EPIDE

53 ×0.6

IMMUN

107 ×1.4

PHYSI

Citations per year, relative to Yin-Hang Yu Yin-Hang Yu (= 1×) peers Bassam Abu‐Libdeh

Countries citing papers authored by Yin-Hang Yu

Since Specialization

Citations

This map shows the geographic impact of Yin-Hang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yin-Hang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yin-Hang Yu more than expected).

Fields of papers citing papers by Yin-Hang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yin-Hang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yin-Hang Yu. The network helps show where Yin-Hang Yu may publish in the future.

Co-authorship network of co-authors of Yin-Hang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yin-Hang Yu. A scholar is included among the top collaborators of Yin-Hang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yin-Hang Yu. Yin-Hang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yu, Yin-Hang, Jinjiao He, Siming Li, et al.. (2016). Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway. International Immunopharmacology. 38. 144–152. 135 indexed citations

Yu, Yin-Hang, Fuliang Bai, Wenfei Wang, et al.. (2015). Fibroblast growth factor 21 protects mouse brain against d-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation. Pharmacology Biochemistry and Behavior. 133. 122–131. 100 indexed citations

Yu, Yin-Hang, Siming Li, Yaonan Liu, et al.. (2015). Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. International Immunopharmacology. 25(1). 74–82. 66 indexed citations

Ren, Guiping, Guiyou Tian, Yunye Liu, et al.. (2015). Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy. Technology in Cancer Research & Treatment. 15(5). NP83–NP94. 25 indexed citations

Li, Siming, Yin-Hang Yu, Lu Li, Wenfei Wang, & Deshan Li. (2015). Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis. Inflammation. 39(1). 309–319. 21 indexed citations

Yu, Yin-Hang, Fuliang Bai, Yaonan Liu, et al.. (2015). Fibroblast growth factor (FGF21) protects mouse liver against d-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways. Molecular and Cellular Biochemistry. 403(1-2). 287–299. 88 indexed citations

Bai, Fuliang, Yin-Hang Yu, Hui Tian, et al.. (2014). Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer Biology & Therapy. 15(9). 1226–1238. 74 indexed citations

Ren, Guiping, Liming Xu, Qiuying Wang, et al.. (2014). Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model. International Immunopharmacology. 21(1). 119–127. 19 indexed citations

Li, Siming, Wenfei Wang, Lihong Zhou, et al.. (2014). Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum. Endocrine. 48(2). 519–527. 27 indexed citations

10.

Li, Siming, Fuliang Bai, Wenjuan Xu, et al.. (2014). Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease. Biologicals. 42(5). 271–276. 11 indexed citations

11.

Yu, Yin-Hang, Guiping Ren, Yaonan Liu, et al.. (2014). [Effect of FGF-21 on learning and memory ability and antioxidant capacity in brain tissue of D-galactose-induced aging mice].. PubMed. 49(7). 1000–6. 2 indexed citations

12.

Han, Xiaohui, Bing Zhou, Wenfei Wang, et al.. (2014). [Therapeutic efficacy of three bispecific antibodies on rheumatoid arthritis mice models].. PubMed. 49(3). 322–8. 1 indexed citations

13.

Wang, Wenfei, Siming Li, Guiping Ren, et al.. (2014). Recombinant murine fibroblast growth factor 21 ameliorates obesity-related inflammation in monosodium glutamate-induced obesity rats. Endocrine. 49(1). 119–129. 47 indexed citations

14.

Han, Miaomiao, Wenfei Wang, Mingyao Liu, et al.. (2014). [FGF-21 protects H9c2 cardiomyoblasts against hydrogen peroxide-induced oxidative stress injury].. PubMed. 49(4). 470–5. 9 indexed citations

15.

Bai, Fuliang, Hui Tian, Yin-Hang Yu, et al.. (2014). TNF-related Apoptosis-inducing Ligand Delivered by rNDV is a Novel Agent for Cancer Gene Therapy. Technology in Cancer Research & Treatment. 14(6). 737–746. 10 indexed citations

16.

Bai, Fuliang, Hui Tian, Mingyao Liu, et al.. (2013). Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis. International Journal of Molecular Medicine. 33(3). 711–721. 14 indexed citations

17.

Ye, Xianlong, et al.. (2013). The Hypoglycemic Effect of The PEGylated FGF-21. ACTA AGRONOMICA SINICA. 40(4). 374–374. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact